Acute myeloid leukaemia (AML) harbouring <i>KMT2A</i> -PTD: should it be considered as a myelodysplasia-related abnormality?
AML harbouring <i>KMT2A</i>-PTD frequently displays MR immunophenotypic abnormalities and is frequently associated with AML-MR type mutations. In addition, they have similar outcomes as compared with AML-MR.
Authors
- Prasanna Bhanshe
- Nilesh Deshpande (ORCID: https://orcid.org/0000-0002-3912-089X)
- Lingaraj Nayak (ORCID: https://orcid.org/0000-0001-9520-795X)
- Bhausaheb Bagal (ORCID: https://orcid.org/0000-0001-9754-0182)
- Narasimhapriyan Kannan (ORCID: https://orcid.org/0000-0003-3688-965X)
- Anant Gokarn (ORCID: https://orcid.org/0000-0002-8725-8375)
- Aarti Ramesh Achrekar
- Vishram Terse
- Nikhil Patkar (ORCID: https://orcid.org/0009-0004-5993-5051)
- Swapnali Joshi
- PG Subramanian
- Shruti Chaudhary
- Sitaram Ghogale
- Pratiksha Salunke
- Vaibhav Gawde
- Sweta Rajpal
- Gaurav Chatterjee
- Hasmukh Jain
- Alok Shetty
- Manju Sengar
- Dhanlaxmi Shetty
- Sumeet Mirgh
- Navin Khattry
- Prashant Tembhare
- Sachin Punatar
Institutions
- Homi Bhabha National Institute (IN)
- Tata Memorial Hospital (IN)
- Advanced Centre for Treatment, Research and Education in Cancer (IN)
Publication Details
- Journal
- Journal of Clinical Pathology
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1136/jcp-2025-210460
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00